- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
迄今为止，共8家主力机构，持仓量总计1029.87万股，占流通A股0.88%
- 波段诊断：
-
技术面诊股
诊断结果：5.6技术面打败了71%的股票
技术面评分前10的股票
近期的平均成本为20.00元，股价在成本上方运行。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为20.00元，股价在成本上方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"20.00","date":1524133475,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2018.04.20","stock":"0.00","trade":"-2.44","ind":"-1.79"},{"date":"2018.04.19","stock":"1.99","trade":"0.28","ind":"1.02"},{"date":"2018.04.18","stock":"-0.76","trade":"1.12","ind":"0.92"},{"date":"2018.04.17","stock":"-4.26","trade":"-2.66","ind":"-2.13"},{"date":"2018.04.16","stock":"-0.91","trade":"-0.58","ind":"-0.61"},{"date":"2018.04.13","stock":"-2.98","trade":"-0.99","ind":"-0.37"},{"date":"2018.04.12","stock":"2.78","trade":"0.66","ind":"-0.75"},{"date":"2018.04.11","stock":"-0.43","trade":"0.71","ind":"0.40"},{"date":"2018.04.10","stock":"1.01","trade":"0.49","ind":"1.05"},{"date":"2018.04.09","stock":"-3.80","trade":"-0.02","ind":"-0.29"},{"date":"2018.04.04","stock":"-0.46","trade":"-0.79","ind":"-0.65"},{"date":"2018.04.03","stock":"-1.36","trade":"0.30","ind":"-0.91"},{"date":"2018.04.02","stock":"2.28","trade":"0.72","ind":"-0.14"},{"date":"2018.03.30","stock":"1.70","trade":"3.12","ind":"1.05"},{"date":"2018.03.29","stock":"1.20","trade":"0.08","ind":"1.18"},{"date":"2018.03.28","stock":"2.50","trade":"1.18","ind":"-1.35"},{"date":"2018.03.27","stock":"0.44","trade":"2.51","ind":"2.00"},{"date":"2018.03.26","stock":"5.51","trade":"3.45","ind":"1.19"},{"date":"2018.03.23","stock":"-3.17","trade":"-5.00","ind":"-4.02"},{"date":"2018.03.22","stock":"0.10","trade":"-0.28","ind":"-0.94"},{"date":"2018.03.21","stock":"-1.29","trade":"-1.73","ind":"-0.88"}]
沃森生物,深证成指,生物制品指数
压力支撑
该股压力位为19.96元，支撑位为19.61元。
[{"text":"\u538b\u529b\u4f4d","value":"19.96","date":1524153600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.61","date":1524153600,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
资金面诊股
诊断结果：3.2资金面打败了26%的股票
主力控盘前10的股票
近5日内该股资金流出较多。据统计，近10日内主力筹码较分散，呈低度控盘状态。
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月20日 20:30
| 机构今日流向(万元) | -1258.40 | 机构5日流向(万元) | -4564.30 |
| 机构10日流向(万元) | -7057.30 | 机构20日流向(万元) | -9026.80 |
机构持仓
2018-03-31 与 2017-12-31 相比，主力机构持仓量减少5373.63万股，其中基金净增仓2家，主力净减仓67家，暂未发现中长期投资价值。
截止2018-03-31，共8家主力机构（基金8家），持仓量总计1029.87万股，占流通A股0.88%
其中，基金持仓与2017-12-31相比：
增仓：4家 ，增持 324.30万股
减仓：2家 ，减持 36.94万股
新出现在主力名单中：2家 ，持有25.41万股
从主力名单中消失：69家 ，原持有5686.4万股
其中，基金持仓与2017-12-31相比：
增仓：4家 ，增持 324.30万股
减仓：2家 ，减持 36.94万股
新出现在主力名单中：2家 ，持有25.41万股
从主力名单中消失：69家 ，原持有5686.4万股
消息面诊股
诊断结果：6.4消息面打败了70%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 沃森生物(300142)04月20日14:30大单
2018-04-20 - 沃森生物(300142)04月20日10:30大单
2018-04-20 - 沃森生物(04月19日)现大宗交易
2018-04-19 - 沃森生物(300142)04月19日14:30大单
2018-04-19 - 沃森生物(300142)04月19日10:30大单
2018-04-19 - 沃森生物(04月18日)现大宗交易
2018-04-18 - 沃森生物(300142)04月18日14:30大单
2018-04-18 - 沃森生物(300142)04月18日10:30大单
2018-04-18 - 沃森生物(300142)04月17日14:30大单
2018-04-17 - 沃森生物(300142)04月17日10:30大单
2018-04-17
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2018-04-13 |
| 利好 | 业绩预告 | 预计扭亏 | 2018-04-10 |
| 一般消息 | 高管变动 | 因个人原因 | 2018-04-04 |
| 利空 | 业绩预告 | 业绩预亏 | 2018-01-13 |
| 一般消息 | 高管变动 | 因个人原因 | 2017-12-28 |
| 一般消息 | 股东大会 | 临时股东大会 | 2017-12-18 |
| 一般消息 | 高管变动 | 因个人原因 | 2017-12-07 |
| 一般消息 | 重大事项 | 关联交易 | 2017-11-03 |
| 一般消息 | 分红转增 | 不分配不转增 | 2017-08-23 |
| 一般消息 | 重大事项 | 关联交易 | 2017-08-23 |
| 一般消息 | 高管变动 | 因工作调整 | 2017-07-21 |
| 一般消息 | 高管变动 | 因工作变动原因 | 2017-07-19 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2017-06-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：6.0行业面打败了81%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2018.04.20","price":"-1.79","value":"-2.44"},{"date":"2018.04.19","price":"1.02","value":"0.28"},{"date":"2018.04.18","price":"0.92","value":"1.12"},{"date":"2018.04.17","price":"-2.13","value":"-2.66"},{"date":"2018.04.16","price":"-0.61","value":"-0.58"},{"date":"2018.04.13","price":"-0.37","value":"-0.99"},{"date":"2018.04.12","price":"-0.75","value":"0.66"},{"date":"2018.04.11","price":"0.40","value":"0.71"},{"date":"2018.04.10","price":"1.05","value":"0.49"},{"date":"2018.04.09","price":"-0.29","value":"-0.02"},{"date":"2018.04.04","price":"-0.65","value":"-0.79"},{"date":"2018.04.03","price":"-0.91","value":"0.30"},{"date":"2018.04.02","price":"-0.14","value":"0.72"},{"date":"2018.03.30","price":"1.05","value":"3.12"},{"date":"2018.03.29","price":"1.18","value":"0.08"},{"date":"2018.03.28","price":"-1.35","value":"1.18"},{"date":"2018.03.27","price":"2.00","value":"2.51"},{"date":"2018.03.26","price":"1.19","value":"3.45"},{"date":"2018.03.23","price":"-4.02","value":"-5.00"},{"date":"2018.03.22","price":"-0.94","value":"-0.28"},{"date":"2018.03.21","price":"-0.88","value":"-1.73"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 东诚生化 | 32.95% | 26.96% | 6.6分 |
| 2 | 东宝生物 | 29.47% | 3.35% | 6.2分 |
| 3 | 博雅生物 | 28.98% | 23.08% | 6.4分 |
| 4 | 金河生物 | 27.63% | 21.36% | 7.0分 |
| 5 | 长春高新 | 16.26% | 6.60% | 7.2分 |
| 6 | 利德曼 | 15.89% | 11.74% | 6.9分 |
| 8 | *ST金泰 | 15.42% | -0.40% | 5.1分 |
| 10 | 常山药业 | 12.83% | 11.65% | 6.6分 |
| 12 | 交大昂立 | 11.95% | 2.70% | 6.3分 |
| 14 | 安科生物 | 11.50% | 5.81% | 6.6分 |
| 16 | 千红制药 | 11.14% | 7.97% | 6.8分 |
| 18 | 四环生物 | 10.57% | 2.11% | 5.4分 |
| 20 | 中源协和 | 9.82% | 3.11% | 6.0分 |
| 22 | 国农科技 | 9.24% | 3.21% | 5.8分 |
| 24 | 科华生物 | 8.58% | 3.65% | 6.7分 |
| 26 | 上海莱士 | 7.40% | 3.33% | 6.3分 |
| 28 | 海普瑞 | 6.86% | 3.63% | 5.5分 |
| 30 | 金花股份 | 6.02% | 3.78% | 5.6分 |
| 32 | *ST四环 | 3.32% | 6.66% | 5.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2017-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 47/159 ， 24/159。
[{"date":"2017-09-30","value":"-1.23","vol":"10.29"},{"date":"2017-06-30","value":"-1.35","vol":"-2.22"},{"date":"2017-03-31","value":"-0.92","vol":"2.63"},{"date":"2016-12-31","value":"2.57","vol":"5.91"},{"date":"2016-09-30","value":"-10.70","vol":"8.73"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-1.23 | -1.35 | -0.92 | 2.57 | -10.70 |
| 行业(%) | 10.29 | -2.22 | 2.63 | 5.91 | 8.73 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2017-09-30","value":"64.33","vol":"62.45"},{"date":"2017-06-30","value":"62.00","vol":"52.10"},{"date":"2017-03-31","value":"55.84","vol":"57.34"},{"date":"2016-12-31","value":"52.50","vol":"53.69"},{"date":"2016-09-30","value":"44.95","vol":"61.37"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
64.33 | 62.00 | 55.84 | 52.50 | 44.95 |
| 行业(%) | 62.45 | 52.10 | 57.34 | 53.69 | 61.37 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 32/159 ， 6/159。
[{"date":"2017-09-30","value":"9.41","vol":"25.16"},{"date":"2017-06-30","value":"-12.39","vol":"851.12"},{"date":"2017-03-31","value":"-59.16","vol":"19.61"},{"date":"2016-12-31","value":"-41.25","vol":"260.06"},{"date":"2016-09-30","value":"-44.10","vol":"14.43"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
9.41 | -12.39 | -59.16 | -41.25 | -44.10 |
| 行业(%) | 25.16 | 851.12 | 19.61 | 260.06 | 14.43 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2017-09-30","value":"83.17","vol":"110.49"},{"date":"2017-06-30","value":"73.43","vol":"285.03"},{"date":"2017-03-31","value":"30.33","vol":"363.09"},{"date":"2016-12-31","value":"108.38","vol":"138.58"},{"date":"2016-09-30","value":"-109.19","vol":"39.15"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
83.17 | 73.43 | 30.33 | 108.38 | -109.19 |
| 行业(%) | 110.49 | 285.03 | 363.09 | 138.58 | 39.15 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 48/159 ， 30/159。
[{"date":"2017-09-30","value":"0.07","vol":"0.35"},{"date":"2017-06-30","value":"0.04","vol":"0.25"},{"date":"2017-03-31","value":"0.01","vol":"0.11"},{"date":"2016-12-31","value":"0.09","vol":"0.58"},{"date":"2016-09-30","value":"0.06","vol":"0.31"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.07 | 0.04 | 0.01 | 0.09 | 0.06 |
| 行业(次) | 0.35 | 0.25 | 0.11 | 0.58 | 0.31 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2017-09-30","value":"0.83","vol":"1.68"},{"date":"2017-06-30","value":"0.55","vol":"2.01"},{"date":"2017-03-31","value":"0.24","vol":"0.51"},{"date":"2016-12-31","value":"1.87","vol":"3.43"},{"date":"2016-09-30","value":"1.52","vol":"1.53"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.83 | 0.55 | 0.24 | 1.87 | 1.52 |
| 行业(次) | 1.68 | 2.01 | 0.51 | 3.43 | 1.53 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2017-09-30","value":"8.37","vol":"13.42"},{"date":"2017-06-30","value":"15.04","vol":"5.57"},{"date":"2017-03-31","value":"-60.98","vol":"-0.60"},{"date":"2016-12-31","value":"42.42","vol":"19.38"},{"date":"2016-09-30","value":"-0.43","vol":"17.41"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 8.37 | 15.04 | -60.98 | 42.42 | -0.43 |
| 行业 | 13.42 | 5.57 | -0.60 | 19.38 | 17.41 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2017-09-30","value":"","vol":"0.00"},{"date":"2017-06-30","value":"3.40","vol":"5.34"},{"date":"2017-03-31","value":"","vol":"0.01"},{"date":"2016-12-31","value":"2.03","vol":"4.22"},{"date":"2016-09-30","value":"","vol":"1.83"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 3.40 | - | 2.03 | - |
| 行业 | 0.00 | 5.34 | 0.01 | 4.22 | 1.83 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/159 ， 9/159。
[{"date":"2017-09-30","value":"1.40","vol":"5.82"},{"date":"2017-06-30","value":"1.45","vol":"8.64"},{"date":"2017-03-31","value":"1.45","vol":"5.46"},{"date":"2016-12-31","value":"1.53","vol":"6.48"},{"date":"2016-09-30","value":"0.80","vol":"5.22"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.40 | 1.45 | 1.45 | 1.53 | 0.80 |
| 行业 | 5.82 | 8.64 | 5.46 | 6.48 | 5.22 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2017-09-30","value":"1.24","vol":"3.77"},{"date":"2017-06-30","value":"1.29","vol":"6.56"},{"date":"2017-03-31","value":"1.33","vol":"3.79"},{"date":"2016-12-31","value":"1.43","vol":"4.82"},{"date":"2016-09-30","value":"0.70","vol":"3.79"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.24 | 1.29 | 1.33 | 1.43 | 0.70 |
| 行业 | 3.77 | 6.56 | 3.79 | 4.82 | 3.79 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 7/159 ， 9/159。
[{"date":"2017-09-30","value":"39.31","vol":"24.06"},{"date":"2017-06-30","value":"39.03","vol":"27.06"},{"date":"2017-03-31","value":"41.33","vol":"25.91"},{"date":"2016-12-31","value":"44.28","vol":"30.35"},{"date":"2016-09-30","value":"58.69","vol":"24.35"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
39.31 | 39.03 | 41.33 | 44.28 | 58.69 |
| 行业(%) | 24.06 | 27.06 | 25.91 | 30.35 | 24.35 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2017-09-30","value":"0.71","vol":"0.43"},{"date":"2017-06-30","value":"0.70","vol":"0.48"},{"date":"2017-03-31","value":"0.78","vol":"0.47"},{"date":"2016-12-31","value":"0.87","vol":"0.65"},{"date":"2016-09-30","value":"1.87","vol":"0.52"}]
| 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.71 | 0.70 | 0.78 | 0.87 | 1.87 |
| 行业(%) | 0.43 | 0.48 | 0.47 | 0.65 | 0.52 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 东兴证券 | 2018-04-11 | 买入 | 买入 |
| 渤海证券 | 2018-04-09 | 增持 | 增持 |
| 西南证券 | 2018-03-28 | 买入 | |
| 方正证券 | 2018-03-14 | 买入 |
机构预测
机构预测该股2017年每股收益与前一年相同，长期投资价值一般。
[{"date":"2013","yellowRectValue":"0.48","blueLineValue":"","type":""},{"date":"2014","yellowRectValue":"1.43","blueLineValue":"","type":""},{"date":"2015","yellowRectValue":"-8.41","blueLineValue":"","type":""},{"date":"2016","yellowRectValue":"0.70","blueLineValue":"","type":""},{"date":"2017","yellowRectValue":"-3.04","blueLineValue":"-0.20","type":"YC"}]